| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-97955-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-97097-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-08992-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-09028-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35234-10ug | |||
| Carrier-Free | NBP2-35234-500ug | |||
| Carrier-Free | NBP2-35234-1000ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75907SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35136-10ug | |||
| Carrier-Free | NBP2-35136-1mg | |||
| Carrier-Free | NBP2-35136-500ug | |||
![Immunohistochemistry-Paraffin: ZAG Antibody [NBP2-97955] - Immunochemical staining of human ZAG in human breast with rabbit polyclonal antibody at 1:1000 dilution, formalin-fixed paraffin embedded sections.](http://images.novusbio.com/fullsize/ZAG-Antibody-Immunohistochemistry-Paraffin-NBP2-97955-img0001.jpg "Immunohistochemistry-Paraffin: ZAG Antibody [NBP2-97955] - Immunochemical staining of human ZAG in human breast with rabbit polyclonal antibody at 1:1000 dilution, formalin-fixed paraffin embedded sections.")
![Immunohistochemistry-Paraffin: ZAG Antibody - BSA Free [NBP2-97955] - Immunochemical staining of human ZAG in human breast with NBP2-97955 at 1:1000 dilution, formalin-fixed paraffin embedded sections.](http://images.novusbio.com/fullsize/nbp2-97955_rabbit-polyclonal-zag-antibody-235202521451747.png)
![Flow Cytometry: Mouse CCR9 mAb (C9Mab-1) [NBP3-14623] - Flow cytometry surface staining pattern of human peripheral whole blood stained using anti-human CD199 (C9Mab-1) purified antibody (concentration in sample 0.5 ug/ml, GAM APC).](http://images.novusbio.com/fullsize/antibody/nbp3-14623_mouse-ccr9-mab-c9mab-1-flow-cytometry-1212202414204..jpg "Flow Cytometry: Mouse CCR9 mAb (C9Mab-1) [NBP3-14623] - Flow cytometry surface staining pattern of human peripheral whole blood stained using anti-human CD199 (C9Mab-1) purified antibody (concentration in sample 0.5 ug/ml, GAM APC).")
![Flow Cytometry: Mouse CCR9 mAb (C9Mab-1) [NBP3-14623] - Separation of human CD20 positive lymphocytes (red-filled) from CD20 negative CD199 negative lymphocytes (black-dashed) in flow cytometry analysis (surface staining) of human peripheral whole blood stained using anti-human CD199 (C9Mab-1) purified antibody (concentration in sample 0.5 ug/ml, GAM APC).](http://images.novusbio.com/fullsize/antibody/nbp3-14623_mouse-ccr9-mab-c9mab-1-flow-cytometry-12122024141531.jpg)
![Flow Cytometry: Mouse CCR9 mAb (C9Mab-1) [NBP3-14623] - Flow cytometry multicolor surface staining pattern of human lymphocytes using anti-human CD199 (C9Mab-1) purified antibody (concentration in sample 0.5 ug/ml, GAM APC) and anti-human CD20 (2H7) Pacific Blue™ antibody (4 μl reagent / 100 μl of peripheral whole blood).](http://images.novusbio.com/fullsize/antibody/nbp3-14623_mouse-ccr9-mab-c9mab-1-flow-cytometry-12122024141756..jpg)
![Western Blot: p67phox/NOXA2 Antibody [NBP2-97097] - Anti-p67phox/NOXA2 rabbit polyclonal antibody at 1:500 dilution. Lane A: THP1 Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 60 kDa. Observed band size: 60 kDa](http://images.novusbio.com/fullsize/p67phox-NOXA2-Antibody-Western-Blot-NBP2-97097-img0004.jpg "Western Blot: p67phox/NOXA2 Antibody [NBP2-97097] - Anti-p67phox/NOXA2 rabbit polyclonal antibody at 1:500 dilution. Lane A: THP1 Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 60 kDa. Observed band size: 60 kDa")
![Immunoprecipitation: p67phox/NOXA2 Antibody [NBP2-97097] - p67phox/NOXA2 was immunoprecipitated using: Lane A: 0.5 mg THP-1 Whole Cell Lysate. 2 ul anti-p67phox/NOXA2 rabbit polyclonal antibody and 15 ul of 50 % Protein G agarose. Primary antibody: Anti-p67phox/NOXA2 rabbit polyclonal antibody, at 1:200 dilution. Secondary antibody: Dylight 800-labeled antibody to rabbit IgG (H+L), at 1:5000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 60 kDa. Observed band size: 60 kDa](http://images.novusbio.com/fullsize/p67phox-NOXA2-Antibody-Immunoprecipitation-NBP2-97097-img0003.jpg)
![Western Blot: TRAF-3 Antibody (PSH01-30) [NBP3-33042] - Western blot analysis of TRAF-3 on different lysates with Rabbit anti-TRAF-3 antibody (NBP3-33042) at 1/1,000 dilution. Lane 1: TF-1 cell lysate (20 ug/Lane) Lane 2: THP-1 cell lysate (20 ug/Lane) Lane 3: 293T cell lysate (20 ug/Lane) Lane 4: Jurkat cell lysate (20 ug/Lane) Lane 5: A549 cell lysate (20 ug/Lane) Lane 6: RAW264.7 cell lysate (20 ug/Lane) Lane 7: NIH/3T3 cell lysate (20 ug/Lane) Lane 8: Mouse brain tissue lysate (40 ug/Lane) Lane 9: Rat spleen tissue lysate (40 ug/Lane) Lysates/proteins at 10 ug/Lane. Predicted band size: 64 kDa Observed band size: 50 kDa Exposure time: 1 minute 9 seconds; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (NBP3-33042) at 1/1,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1:50,000 dilution was used for 1 hour at room temperature.](http://images.novusbio.com/fullsize/nbp3-33042_rabbit-traf-3-mab-psh01-30-288202412493419.jpg "Western Blot: TRAF-3 Antibody (PSH01-30) [NBP3-33042] - Western blot analysis of TRAF-3 on different lysates with Rabbit anti-TRAF-3 antibody (NBP3-33042) at 1/1,000 dilution. Lane 1: TF-1 cell lysate (20 ug/Lane) Lane 2: THP-1 cell lysate (20 ug/Lane) Lane 3: 293T cell lysate (20 ug/Lane) Lane 4: Jurkat cell lysate (20 ug/Lane) Lane 5: A549 cell lysate (20 ug/Lane) Lane 6: RAW264.7 cell lysate (20 ug/Lane) Lane 7: NIH/3T3 cell lysate (20 ug/Lane) Lane 8: Mouse brain tissue lysate (40 ug/Lane) Lane 9: Rat spleen tissue lysate (40 ug/Lane) Lysates/proteins at 10 ug/Lane. Predicted band size: 64 kDa Observed band size: 50 kDa Exposure time: 1 minute 9 seconds; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (NBP3-33042) at 1/1,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1:50,000 dilution was used for 1 hour at room temperature.")
![Recombinant Human NLRP3/NALP3 Protein [H00114548-Q01] - 12.5% SDS-PAGE Stained with Coomassie Blue.](http://images.novusbio.com/fullsize/qc_test-H00114548-Q01-1.jpg "Recombinant Human NLRP3/NALP3 Protein [H00114548-Q01] - 12.5% SDS-PAGE Stained with Coomassie Blue.")
![Western Blot: Insulin Antibody [NBP1-45662] - Analysis using recombinant human Insulin.](http://images.novusbio.com/fullsize/Insulin-Antibody-Western-Blot-NBP1-45662-img0002.jpg "Western Blot: Insulin Antibody [NBP1-45662] - Analysis using recombinant human Insulin.")
![SDS-Page: Complement C3 Partial Recombinant Protein [H00000718-Q01]](http://images.novusbio.com/fullsize/Complement-C3-Partial-Recombinant-Protein-SDS-Page-H00000718-Q01-img0001.jpg "SDS-Page: Complement C3 Partial Recombinant Protein [H00000718-Q01]")
![SDS-Page: Porcine CXCL8/IL-8 Protein [NBP2-35234]](http://images.novusbio.com/fullsize/Porcine-CXCL8-IL-8-Protein-SDS-Page-NBP2-35234-img0001.jpg "SDS-Page: Porcine CXCL8/IL-8 Protein [NBP2-35234]")
![Western Blot: CD40 Ligand/TNFSF5 Antibody (hu5c8 (Ruplizumab)) [NBP2-75907] - Rat spleen (lane 1), rat muscle (lane 2), rat bladder (lane 3), human breast tumour (lane 4) and human thyroid tumour (lane 5) samples were resolved on a 10% SDS PAGE gel and blots probed with NBP2-75907 at 1 ug/ml before being detected by a secondary antibody. The expected band size (29 kDa) is seen in the human-derived samples, as well as bands corresponding to dimers and other multimers.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-hu5c8-Ruplizumab-Western-Blot-NBP2-75907-img0001.jpg "Western Blot: CD40 Ligand/TNFSF5 Antibody (hu5c8 (Ruplizumab)) [NBP2-75907] - Rat spleen (lane 1), rat muscle (lane 2), rat bladder (lane 3), human breast tumour (lane 4) and human thyroid tumour (lane 5) samples were resolved on a 10% SDS PAGE gel and blots probed with NBP2-75907 at 1 ug/ml before being detected by a secondary antibody. The expected band size (29 kDa) is seen in the human-derived samples, as well as bands corresponding to dimers and other multimers.")
![SDS-Page: Mouse IL-7 Protein [NBP2-35136]](http://images.novusbio.com/fullsize/Mouse-IL-7-Protein-SDS-Page-NBP2-35136-img0001.jpg "SDS-Page: Mouse IL-7 Protein [NBP2-35136]")